All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: HIV Infections-27177767
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 27177767 A124N
IN
gag-pol
HIV Infections
D
G
C
L
View
2 27177767 A124T
IN
gag-pol
HIV Infections
D
G
C
L
View
3 27177767 C130Y
IN
gag-pol
HIV Infections
D
G
C
L
View
4 27177767 C56S
IN
gag-pol
HIV Infections
D
G
C
L
View
5 27177767 D55Y
IN
gag-pol
HIV Infections
D
G
C
L
View
6 27177767 E157A
IN
gag-pol
HIV Infections
D
G
C
L
View
7 27177767 E85E
IN
gag-pol
HIV Infections
D
G
C
L
View
8 27177767 E85G
IN
gag-pol
HIV Infections
D
G
C
L
View
9 27177767 E96D
IN
gag-pol
HIV Infections
D
G
C
L
View
10 27177767 G123R
IN
gag-pol
HIV Infections
D
G
C
L
View
11 27177767 G123S
IN
gag-pol
HIV Infections
D
G
C
L
View
12 27177767 G134E
IN
gag-pol
HIV Infections
D
G
C
L
View
13 27177767 G163G
IN
gag-pol
HIV Infections
D
G
C
L
View
14 27177767 G163R
IN
gag-pol
HIV Infections
D
G
C
L
View
15 27177767 G52P
IN
gag-pol
HIV Infections
D
G
C
L
View
16 27177767 H171Q
IN
gag-pol
HIV Infections
D
G
C
L
View
17 27177767 I113V
IN
gag-pol
HIV Infections
D
G
C
L
View
18 27177767 I161X
IN
gag-pol
HIV Infections
D
G
C
L
View
19 27177767 K103R
IN
gag-pol
HIV Infections
D
G
C
L
View
20 27177767 K111T
IN
gag-pol
HIV Infections
D
G
C
L
View
21 27177767 K156N
IN
gag-pol
HIV Infections
D
G
C
L
View
22 27177767 K160K
IN
gag-pol
HIV Infections
D
G
C
L
View
23 27177767 K160T
IN
gag-pol
HIV Infections
D
G
C
L
View
24 27177767 K173E
IN
gag-pol
HIV Infections
D
G
C
L
View
25 27177767 K173K
IN
gag-pol
HIV Infections
D
G
C
L
View
26 27177767 L101I
IN
gag-pol
HIV Infections
D
G
C
L
View
27 27177767 L68R
IN
gag-pol
HIV Infections
D
G
C
L
View
28 27177767 L74I
IN
gag-pol
HIV Infections
D
G
C
L
View
29 27177767 L74M
IN
gag-pol
HIV Infections
D
G
C
L
View
30 27177767 M50I
IN
gag-pol
HIV Infections
D
G
C
L
View
31 27177767 M50M
IN
gag-pol
HIV Infections
D
G
C
L
View
32 27177767 M50V
IN
gag-pol
HIV Infections
D
G
C
L
View
33 27177767 N155H
IN
gag-pol
HIV Infections
D
G
C
L
View
34 27177767 P90P
IN
gag-pol
HIV Infections
D
G
C
L
View
35 27177767 P90S
IN
gag-pol
HIV Infections
D
G
C
L
View
36 27177767 S119P
IN
gag-pol
HIV Infections
D
G
C
L
View
37 27177767 S119R
IN
gag-pol
HIV Infections
D
G
C
L
View
38 27177767 T122I
IN
gag-pol
HIV Infections
D
G
C
L
View
39 27177767 T125A
IN
gag-pol
HIV Infections
D
G
C
L
View
40 27177767 T97A
IN
gag-pol
HIV Infections
D
G
C
L
View
41 27177767 V150A
IN
gag-pol
HIV Infections
D
G
C
L
View
42 27177767 V150V
IN
gag-pol
HIV Infections
D
G
C
L
View
43 27177767 V151I
IN
gag-pol
HIV Infections
D
G
C
L
View
44 27177767 V71I
IN
gag-pol
HIV Infections
D
G
C
L
View
45 27177767 V72I
IN
gag-pol
HIV Infections
D
G
C
L
View
46 27177767 Y99C
IN
gag-pol
HIV Infections
D
G
C
L
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.